Long-term survival after treatment with gemcitabine and oxaliplatin with and without paclitaxel plus secondary surgery in patients with cisplatin-refractory and/or multiply relapsed germ cell tumors.
Standard
Long-term survival after treatment with gemcitabine and oxaliplatin with and without paclitaxel plus secondary surgery in patients with cisplatin-refractory and/or multiply relapsed germ cell tumors. / Oechsle, Karin; Kollmannsberger, Christian; Honecker, Friedemann; Mayer, Frank; Waller, Cornelius F; Hartmann, Jörg T; Boehlke, Ina; Bokemeyer, Carsten; Group, German Testicular Cancer Study.
In: EUR UROL, Vol. 60, No. 4, 4, 2011, p. 850-855.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Long-term survival after treatment with gemcitabine and oxaliplatin with and without paclitaxel plus secondary surgery in patients with cisplatin-refractory and/or multiply relapsed germ cell tumors.
AU - Oechsle, Karin
AU - Kollmannsberger, Christian
AU - Honecker, Friedemann
AU - Mayer, Frank
AU - Waller, Cornelius F
AU - Hartmann, Jörg T
AU - Boehlke, Ina
AU - Bokemeyer, Carsten
AU - Group, German Testicular Cancer Study
PY - 2011
Y1 - 2011
N2 - Chemotherapy including gemcitabine, oxaliplatin, and/or paclitaxel has shown efficacy in germ cell tumor patients after progression during cisplatin-based chemotherapy or relapse after high-dose chemotherapy including complete responses in 5-15%.
AB - Chemotherapy including gemcitabine, oxaliplatin, and/or paclitaxel has shown efficacy in germ cell tumor patients after progression during cisplatin-based chemotherapy or relapse after high-dose chemotherapy including complete responses in 5-15%.
KW - Adult
KW - Humans
KW - Male
KW - Middle Aged
KW - Young Adult
KW - Treatment Outcome
KW - Clinical Trials, Phase II as Topic
KW - Retrospective Studies
KW - Salvage Therapy
KW - Antineoplastic Agents/therapeutic use
KW - Antineoplastic Combined Chemotherapy Protocols/therapeutic use
KW - Cisplatin/therapeutic use
KW - Deoxycytidine/analogs & derivatives/therapeutic use
KW - Neoplasms, Germ Cell and Embryonal/drug therapy/mortality/surgery
KW - Organoplatinum Compounds/therapeutic use
KW - Paclitaxel/therapeutic use
KW - Testicular Neoplasms/drug therapy/mortality/surgery
KW - Adult
KW - Humans
KW - Male
KW - Middle Aged
KW - Young Adult
KW - Treatment Outcome
KW - Clinical Trials, Phase II as Topic
KW - Retrospective Studies
KW - Salvage Therapy
KW - Antineoplastic Agents/therapeutic use
KW - Antineoplastic Combined Chemotherapy Protocols/therapeutic use
KW - Cisplatin/therapeutic use
KW - Deoxycytidine/analogs & derivatives/therapeutic use
KW - Neoplasms, Germ Cell and Embryonal/drug therapy/mortality/surgery
KW - Organoplatinum Compounds/therapeutic use
KW - Paclitaxel/therapeutic use
KW - Testicular Neoplasms/drug therapy/mortality/surgery
M3 - SCORING: Journal article
VL - 60
SP - 850
EP - 855
JO - EUR UROL
JF - EUR UROL
SN - 0302-2838
IS - 4
M1 - 4
ER -
